Widening Sino‐EU policy and research cooperation in Personalised Medicine

Informazioni relative al progetto

SINO-EU-PerMed

ID dell’accordo di sovvenzione: 874556

DOI

10.3030/874556

Progetto chiuso

Data della firma CE 2 Dicembre 2019

Data di avvio 1 Gennaio 2020

Data di completamento 30 Giugno 2024

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 2 338 650,00

Contributo UE

€ 1 999 250,00

Coordinato da

DEUTSCHES ZENTRUM FUR LUFT - UND RAUMFAHRT EV
Germany

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (9)

Workshop report

Report of the Stakeholder-Workshop

Action plan for the alignment of Chinese organisation with ICPerMed

The task will support the active relationship between ICPerMed and this initiative This is important for cooperation and alignment with ICPerMed to leverage possible synergies Feedback on strategic developments of ICPerMed is expected as well as a wider communication and dissemination of ICPerMed activities A dialogue will be established with representatives of ICPerMed eligible funding bodies and policymaking institutions to foster the consideration of Chinese requirements by ICPerMed bodies in a crosssectional approach Stakeholders identified within WP2 will be targeted and supported in active participation in ICPerMed activities and usage of ICPerMed tools eg website newsletter partnering platform funding database

Report of 2nd Sino-EU-PerMed S&T Workshop

The 2nd Sino-EU‐PerMed Technical Workshop will be held in China around M40. The workshop will discuss selected issues identified in the WP2 mapping, as well as regulatory aspects, data and legal perspectives, e.g. data standards and interoperability, data collection, storage, curation, and security, multimodal data analysis and artificial intelligence (AI) algorithms for patient stratification, as well as data protection legislation. In addition, follow up discussions from the 1st workshop might be included if considered relevant.

Report: Mapping the scientific and Policy Landscape of PerMed in China, including the identification of stakeholders

A systematic mapping of available literature (scientific papers and patents) will be carried out to describe, in a comprehensive, transparent and objective manner the R&I landscape of PerMed in China, the main areas in which research is being performed, and innovation activities and cooperation with European researchers.The results of this mapping will be an important input to activities in WP 3 and 4.

Report: Preliminary analysis of Strengths, Weaknesses, Barriers and Gaps for ICPerMed‐China Cooperation. Document for discussion in the workshop

Results of the previous tasks will be used to prepare a first analysis of the context of PerMed in China, in terms of Research effort, policy commitment and relevance within the main stakeholder groups. This first analysis will provide a first insight on: countries where Personalised Medicine is already an issue of interest; countries which already have research groups working in this field, how far PM is being contemplated or up taken in public health policies, who are the main actors to be addressed for the sake of the project's objective, etc.

Report of 1st Sino-EU-PerMed S&T Workshop

The 1st Sino-EU‐PerMed S&T Workshop will be held in Europe around M24 and will be focused, among other selected topics, on ‐omics technologies, exposome data integration, clinical trial methodologies, trial designs for PerMed (basket, umbrella, platform trials), set‐up of cohorts, informed consent, patient engagement, etc. In addition, the socio‐ economic impact of PerMed approaches discussed at the workshop will also be addressed from both a Chinese as well as a European point of view.

Policy Brief: Barriers and needs for Bi-Regional cooperation in PerMed between EU and China

Results of the Workshop discussions will serve to refine to draft document prepared in Task 2.4. The document will serve as a starting point for the Science and Policy Dialogue to be carried out in WP3.

Policy briefing and guidelines on ELSA for PerMed

A Policy Brief including recommendations for harmonisation of ELSA in PerMed will be elaborated by the ELSA Task Force based on the outcomes of the workshop.

Update Mapping

a new deliverable has been proposed D2.5 (D18) (New S&T Mapping 2023) at M41with the aim to get an updated analysis of the data from 2020, thereby grasping an important insight into the changes in the Sino-EU Cooperation in Personalised Medicine over the past years. The budgetary resources necessary to cover this new task (approx. 20.000 EUR) come from savings due to the switch to a hybrid event for MS8, and unused external travel costs.

Pubblicazioni

Non-peer reviewed articles (1)

Mapping Of The Sino-European Science And Technology Collaborations On Personalized Medicine: An Updated Overview

Autori: Letizia Pontoriero, Andrea Mazzoni, Giovanni de Santis, Matteo Gentili, Ejner Moltzen, Sabine Puch, Carolin Lange, Andrea Frosini, Gianni D’Errico
Pubblicato in: MedrXiv, 2024, ISSN 2692-8205
Editore: Cold Spring Habor Laboratory
DOI: 10.1101/2024.06.27.24309578

Peer reviewed articles (1)

Sino-European science and technology collaboration on personalized medicine: overview, trends and future perspectives

Autori: Romagnuolo, Ilaria; Mariut, Claudia; Mazzoni, Andrea; Santis, Giovanni de; Moltzen, Ejner; Ballensiefen, Wolfgang; Lange, Carolin; Frosini, Andrea; D'Errico, Gianni
Pubblicato in: Future Medicine, 2021, ISSN 1741-0541
Editore: Future Medicine Ltd.
DOI: 10.2217/pme-2021-0030